Stability of warfarin sodium flavoured preservative-free oral liquid formulations

被引:3
|
作者
Schlatter, Joel [1 ]
Cisternino, Salvatore [1 ,2 ]
机构
[1] Hop Univ Necker Enfants Malad, Pharm Clin, Paris, France
[2] Univ Paris 05, Fac Pharm, UMR S 1144, Paris, France
关键词
formulation; pediatric; preservative-free; sodium warfarin; stability;
D O I
10.1136/ejhpharm-2017-001281
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives This study was designed to assess the physicochemical stability of warfarin sodium liquid formulations stored at room temperature and under refrigeration. Methods Formulations of warfarin sodium 1mg/mL were prepared from either powder or tablets dispersed in mixture containing deionised water, glycerin, sodium phosphate and strawberry alcohol-free concentrate flavour and stored in amber glass bottles at 25 degrees C and 4 degrees C. Stability indicating high-performance liquid chromatography assay procedure was used to analyse the concentration of the drug at the time of preparation and on days 7, 14, 21, 30, 45, 60 and 90. Changes in colour, taste and pH, as well as visual evidence of precipitation, were assessed for physicochemical instability. Results Between day 0 and day 90, the pH of the powder and tablet formulations stored at 25 degrees C decreased by -1.40 units and -1.16 units, respectively. There were minor changes in pH for both formulations stored at 4 degrees C. The formulation from powder stored at 25 degrees C and 4 degrees C maintained at least 90% of the initial warfarin concentration for 30 days and 45 days, respectively. The formulation from tablets stored at 25 degrees C and 4 degrees C maintained at least 90% of initial warfarin concentration for 21 days and 30 days, respectively. Conclusion Warfarin sodium in flavoured preservativefree formulation from powder is recommended and stable in amber glass bottles for at least 30 days stored at 25 degrees C and 45 days stored at 4 degrees C.
引用
收藏
页码:E98 / E101
页数:4
相关论文
共 50 条
  • [41] STABILITY OF ALCOHOL-FREE THEOPHYLLINE LIQUID REPACKAGED IN PLASTIC ORAL SYRINGES
    JOHNSON, CE
    DRABIK, BT
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1989, 46 (05): : 980 - 981
  • [42] Efficacy and Safety of Preoperative IOP Reduction better for Preservative-free Fixed Combination of Dorzolamide/timolol Eye Drops versus Oral Acetazolamide and Dexamethasone Eye Drops for Outcome of Trabeculectomy
    Lorenz, Katrin
    Wasielica-Poslednik, Joanna
    Bell, Katharina
    Renieri, Guilia
    Keicher, Alexander
    Ruckes, Christian
    Pfeiffer, Norbert
    Thieme, Hagen
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [43] Evaluation of ocular surface disease symptoms and patient satisfaction in dry eye disease after 84 days of treatment with preservative-free eye drops containing sodium hyaluronate and trehalose
    Mateo-Otobia, Antonio
    Sanz, Eduardo Del Prado
    Martinez, Alejandro Blasco
    Corta, Miriam Idoipe
    Sanz, Maria Romero
    Julvez, Luis E. Pablo
    Farrant, Sarah
    ACTA OPHTHALMOLOGICA, 2022, 100
  • [44] Patient-reported outcomes measurements in dry eye patients after 84 days of daily treatment with a preservative-free combination containing sodium hyaluronate and trehalose: The TEARS study
    Mateo-Otobia, Antonio
    Chassany, Olivier
    Duracinsky, Martin
    ACTA OPHTHALMOLOGICA, 2022, 100
  • [45] Stability of oral liquid preparations of tramadol in strawberry syrup and a sugar-free vehicle
    Wagner, DS
    Johnson, CE
    Cichon-Hensley, BK
    DeLoach, SL
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (12) : 1268 - 1270
  • [46] Management of Oxidative Stress and Inflammation in Patients with Symptomatic Dry Eye Disease Treated with a Preservative-Free Ophthalmic Emulsion Combining Alpha-Lipoic Acid and High Molecular Weight Sodium Hyaluronate
    Chauchat, Laure
    Guerin, Camille
    Sahyoun, Marwan
    Guillon, Michel
    Calonge, Margarita
    ADVANCES IN THERAPY, 2025, : 2219 - 2233
  • [47] Development, Quality by Design-Based Optimization, and Stability Assessment of Oral Liquid Formulations Containing Baclofen for Hospital Use
    Simon, Elisa de Saldanha
    Wingert, Nathalie Ribeiro
    Gobetti, Caren
    Primieri, Gabriele Bordignon
    Ayres, Marcio Vinicius
    Oliveira de Almeida, Silvia Helena
    Volpato, Nadia Maria
    Steppe, Martin
    AAPS PHARMSCITECH, 2022, 23 (08)
  • [48] Development, Quality by Design-Based Optimization, and Stability Assessment of Oral Liquid Formulations Containing Baclofen for Hospital Use
    Elisa de Saldanha Simon
    Nathalie Ribeiro Wingert
    Caren Gobetti
    Gabriele Bordignon Primieri
    Márcio Vinícius Ayres
    Silvia Helena Oliveira de Almeida
    Nadia Maria Volpato
    Martin Steppe
    AAPS PharmSciTech, 23
  • [49] The new once- daily multidose preservative-free 0.6% bilastine eye drop formulation containing sodium hyaluronate preserves ocular surface integrity and tear film homeostasis in a comparative in vivo study
    Suarez-Cortes, Tatiana M.
    Arana, Eider
    Gonzalo, Ana
    Zazpe, Arturo
    Torrens, Ines
    Andollo, Noelia
    Soria, Javier
    Hernandez, Gonzalo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [50] Efficacy and safety of preoperative lop reduction using a preservative-free fixed combination of dorzolamide/timolol eye drops versus oral acetazolamide and dexamethasone eye drops and assessment of the clinical outcome of trabeculectomy in glaucoma
    Lorenz, Katrin
    Wasielica-Poslednik, Joanna
    Bell, Katharina
    Renieri, Giulia
    Keicher, Alexander
    Ruckes, Christian
    Pfeiffer, Norbert
    Thieme, Hagen
    PLOS ONE, 2017, 12 (02):